ATE345809T1 - Arzneimittelzusammensetzung enthaltend tcf-ii - Google Patents

Arzneimittelzusammensetzung enthaltend tcf-ii

Info

Publication number
ATE345809T1
ATE345809T1 AT97100939T AT97100939T ATE345809T1 AT E345809 T1 ATE345809 T1 AT E345809T1 AT 97100939 T AT97100939 T AT 97100939T AT 97100939 T AT97100939 T AT 97100939T AT E345809 T1 ATE345809 T1 AT E345809T1
Authority
AT
Austria
Prior art keywords
composition containing
medicinal composition
tcf
containing tcf
derived
Prior art date
Application number
AT97100939T
Other languages
English (en)
Inventor
Hiroaki Masunaga
Nobuaki Fujise
Kanji Higashi
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP21222992A external-priority patent/JP3380573B2/ja
Priority claimed from JP21222792A external-priority patent/JP3619526B2/ja
Priority claimed from JP4234198A external-priority patent/JPH0656692A/ja
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Application granted granted Critical
Publication of ATE345809T1 publication Critical patent/ATE345809T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Surgery (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT97100939T 1992-07-16 1993-07-16 Arzneimittelzusammensetzung enthaltend tcf-ii ATE345809T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP21222992A JP3380573B2 (ja) 1992-07-16 1992-07-16 Ｔｃｆ−ｉｉを有効成分とする蛋白合成促進剤
JP21222792A JP3619526B2 (ja) 1992-07-16 1992-07-16 Ｔｃｆ−ｉｉを有効成分とする肝臓疾患治療剤
JP4234198A JPH0656692A (ja) 1992-08-10 1992-08-10 Ｔｃｆ−ｉｉを有効成分とする創傷治療剤

Publications (1)

Publication Number Publication Date
ATE345809T1 true ATE345809T1 (de) 2006-12-15

Family

ID=27329338

Family Applications (3)

Application Number Title Priority Date Filing Date
AT93305602T ATE159171T1 (de) 1992-07-16 1993-07-16 Arzneimittelzusammensetzung enthaltend tcf-ii
AT97100939T ATE345809T1 (de) 1992-07-16 1993-07-16 Arzneimittelzusammensetzung enthaltend tcf-ii
AT06076444T ATE428438T1 (de) 1992-07-16 1993-07-16 Tcf-ii enthaltende medizinische zusammensetzung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT93305602T ATE159171T1 (de) 1992-07-16 1993-07-16 Arzneimittelzusammensetzung enthaltend tcf-ii

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT06076444T ATE428438T1 (de) 1992-07-16 1993-07-16 Tcf-ii enthaltende medizinische zusammensetzung

Country Status (7)

Country Link
EP (3) EP1719522B1 (de)
KR (1) KR100271087B1 (de)
AT (3) ATE159171T1 (de)
CA (1) CA2100720C (de)
DE (3) DE69334087T2 (de)
DK (2) DK0588477T3 (de)
ES (2) ES2276409T3 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69330960T2 (de) * 1992-07-16 2002-04-11 Snow Brand Milk Products Co., Ltd. Normalisierer der blutkoagulation enthaltend tcf-ii als aktiven bestandteil
JP3402476B2 (ja) * 1992-08-24 2003-05-06 生化学工業株式会社 リポ多糖結合性タンパク質及びその製造法
JP3680114B2 (ja) * 1993-09-17 2005-08-10 敏一 中村 脳神経障害治療剤
NZ298141A (en) * 1994-12-27 2000-12-22 Snow Brand Milk Products Co Ltd Treating lipid metabolism disorder using TCF-II
JP4006058B2 (ja) 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
DK0950416T3 (da) 1997-03-14 2007-02-26 Daiichi Seiyaku Co Anvendelse af TCF-II til behandling af cancerrelateret tab af kropsvægt, anæmi og TNF-forhöjelse
JP3961064B2 (ja) 1997-03-28 2007-08-15 第一製薬株式会社 腎疾患予防及び／又は治療剤
JPH1129493A (ja) * 1997-07-14 1999-02-02 Snow Brand Milk Prod Co Ltd 放射線障害予防及び／又は治療剤
JPH11269091A (ja) * 1998-03-19 1999-10-05 Snow Brand Milk Prod Co Ltd 敗血症予防及び／又は治療剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904753A (en) * 1970-02-20 1975-09-09 Research Corp Clinically active bovine growth hormone fraction
JPS58146293A (ja) 1982-02-26 1983-08-31 Mochida Pharmaceut Co Ltd 抗腫瘍性糖蛋白質の製造方法
US4708948A (en) 1984-04-20 1987-11-24 The United States Of America As Represented By The Department Of Health And Human Services Substantially purified tumor growth inhibitory factor
DE3419184A1 (de) 1984-05-23 1985-11-28 Dr.Ing.H.C. F. Porsche Ag, 7000 Stuttgart Zuendverteileranordnung an brennkraftmaschinen
JPS62103021A (ja) 1985-10-28 1987-05-13 Yoshitomi Pharmaceut Ind Ltd 細胞障害作用を有する生理活性物質およびその製造方法
JP2564486B2 (ja) * 1986-07-14 1996-12-18 修治 橋本 肝細胞増殖因子
JPS6410998A (en) 1986-12-22 1989-01-13 Green Cross Corp Tumor cell inhibitory factor
NZ232813A (en) * 1989-03-10 1992-08-26 Snow Brand Milk Products Co Ltd Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons
US5035887A (en) * 1989-09-07 1991-07-30 Institute Of Moelcular Biology, Inc. Wound healing composition of IL-1 and PDGF or IGF-1
EP0461560B1 (de) * 1990-06-11 1998-11-18 Toshikazu Nakamura Rekombinanter menschlicher Hepatozytwachstumsfaktor und Verfahren zu seiner Herstellung
DE69131069T2 (de) 1990-07-13 1999-07-15 Snow Brand Milk Products Co., Ltd., Sapporo, Hokkaido Plasmid das für die aminosäuresequenz von tcf-ii kodierende dns enthalt, transformierte zelle und produktion einer physiologisch aktiven substanz mit ihrer verwendung

Also Published As

Publication number Publication date
KR100271087B1 (en) 2000-11-01
ES2276409T3 (es) 2007-06-16
EP1719522B1 (de) 2009-04-15
KR940005286A (ko) 1994-03-21
ATE159171T1 (de) 1997-11-15
EP1719522A1 (de) 2006-11-08
EP0821969B1 (de) 2006-11-22
AU4194593A (en) 1994-01-20
EP0588477B1 (de) 1997-10-15
DE69314586T2 (de) 1998-02-19
EP0588477A2 (de) 1994-03-23
ES2110057T3 (es) 1998-02-01
DK0821969T3 (da) 2007-03-26
EP0821969A3 (de) 2000-12-13
DE69334281D1 (de) 2009-05-28
DE69334087T2 (de) 2007-07-05
CA2100720C (en) 2003-03-11
EP0588477A3 (en) 1994-05-25
DE69314586D1 (de) 1997-11-20
EP0821969A2 (de) 1998-02-04
AU673835B2 (en) 1996-11-28
ATE428438T1 (de) 2009-05-15
CA2100720A1 (en) 1994-01-17
DE69334087D1 (de) 2007-01-04
DK0588477T3 (da) 1998-03-30

Similar Documents

Publication Publication Date Title
FI933770A7 (fi) Farmaseuttisia koostumuksia ihotautien hoitamiseen
UA42747C2 (uk) Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
ATE237303T1 (de) Verwendung von zusammensetzungen mit benzoylperoxyd, glycolsäure und zink zur behandlung von dermatologischen krankheiten
BR9106891A (pt) Composiçoes para o tratamento da pele
NO910340L (no) Topiske preparater for behandling av menneskenegler.
MX9801596A (es) Composiciones aliviadoras del prurito, cosmeticas y farmaceuticas o ambas.
NO20004282D0 (no) Matriksproteinpreparater for sÕrheling
DE68913739D1 (de) Kosmetische und hautbehandlungs-zusammensetzungen.
GR3035762T3 (en) Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses
ATE345809T1 (de) Arzneimittelzusammensetzung enthaltend tcf-ii
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
IT1240683B (it) Composizione farmaceutica contenente egf
ATE151774T1 (de) Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
GR3032224T3 (en) Therapeutic agent for threatened abortion.
TR199901385T2 (xx) Piperidin t�revleri.
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
DE69327693D1 (de) Interferon-Alpha/Beta bindendes Protein, seine Herstellung und seine enthaltende pharmazeutische Zusammensetzungen
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
DE59101818D1 (de) Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.
DE69719190D1 (de) Kolostrum enthaltende pharmazeutische zusammensetzungen und deren verwendung
DE69330809D1 (de) Therapeutisches Agens für Neutropenie
ZA979135B (en) New cosmetic, dermopharmaceutical or veterinary compositions for the antiseptic treatment of human or animal skin.
ATE102478T1 (de) Kosmetische und hautbehandlungszusammensetzungen.
KR930703003A (ko) 피부질환치료용 제약 조성물
DE68914886D1 (de) Mittel zur Behandlung von Raynaud's Krankheit.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0821969

Country of ref document: EP

EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee